Department of neurology
UAB neurologists are expanding global health efforts in Kenya by providing neurological care and medical training in Kijabe, addressing specialty care shortages and strengthening global partnerships.
UAB is leading a national study examining how personalized genetic risk information can improve prevention of chronic diseases, helping guide earlier screening, treatment and clinical decision‑making.
David G. Standaert, M.D., Ph.D., chair of UAB’s Department of Neurology, joins the inaugural Advisory Council on Parkinson’s Research, Care, and Services to work toward a world without Parkinson’s disease.
UAB researchers discover the mechanism by which neurofibrillary tangles spread through the brain of Alzheimer’s patients is via connected neurons, and these findings reveal a major disease etiology that could lead to new therapies that slow Alzheimer’s disease progression.
A rise in research funding within UAB’s Department of Family and Community Medicine highlights its expanding research impact.
Procedures that remove plaque from a narrowed carotid artery in the neck or prop the artery open with a stent did not appear to be better at improving cognitive function than medications and lifestyle changes.
UAB researchers share a discovery that could pave the way for non‑addictive alternatives to opioid painkillers amid an era of rising overdose deaths.
A new UAB study could help doctors better understand a chronic pain-causing condition associated with diabetes mellitus and ultimately improve pain relief treatment options for diabetic patients.
New research co-led by the UAB School of Public Health could reshape treatment guidelines for asymptomatic carotid stenosis, a condition caused by a buildup of plaque in arteries that carry blood to the brain.
Learn about epilepsy, types of seizures, common symptoms, warning signs and how to provide seizure first aid.
UAB experts offer insight on Tourette syndrome, and the care patients may need after diagnosis.
Until now, treatments have only managed symptoms, rather than altering the disease’s course.
New clinical services and specialty programs are expanding access to high-quality care in Birmingham and throughout Alabama.
A UAB neurologist shares how symptoms of various movement disorders can be treated with deep brain stimulation therapy.
The published study found a correlation between first-time transient ischemic attack and future cognitive decline. Rates of decline between TIA and stroke participants were the same.
Knowing the symptoms and acting quickly in a stroke emergency can help to minimize long-term effects.
Chronic stress can increase inflammation in the brain, which can impact sleep, cognition and memory and potentially increase one’s risk for neurodegenerative diseases.
The Killion family of Birmingham has given a $10 million gift to UAB to create the Wayne Killion Endowment for the Center for Neurodegeneration and Experimental Therapeutics and to rename the center the Killion Center for Neurodegeneration and Experimental Therapeutics.
Via virtual submissions, UAB Medicine now offers remote second opinions from specialized care experts on diagnoses and treatment options.
Rachel Smith, Ph.D., is collaborating with researchers across UAB on the two-year project, which will focus on the intracranial neural networks responsible for major depressive symptoms in epilepsy patients.